Valeryia Ziablava

Valeryia Ziablava's work experience begins with their current role as Associate Director of Logistics and Commercial Distribution at Agios Pharmaceuticals, where they have been working since March 2023. Prior to this, they held the position of Senior Logistics Manager at the same company from November 2020 to March 2023.

Before joining Agios Pharmaceuticals, Valeryia worked as a Logistics Manager at Kiniksa Pharmaceuticals from July 2018 to November 2020. Prior to that, they were a Supply Chain Coordinator at Jibo, Inc. from February 2018 to July 2018.

Valeryia's earlier experience includes working as an Operations Project Associate at athenahealth from December 2016 to February 2018. Before that, they held various roles at Hologic, Inc., including Manager of Global Service Logistics Support from September 2014 to December 2016, Supervisor of Global Service Logistics Support from January 2012 to September 2014, and Logistics Administrator from June 2008 to January 2012.

Valeryia's career started in 2006 at Intetics in Minsk, Belarus, where they worked as a Business Development Manager until May 2008. Prior to that, they worked as an Expert on External Economic Links at Gidrotechsnab from September 2004 to October 2006.

Before entering the corporate world, Valeryia worked as an interpreter for Independent Children's Aid in Minsk, Belarus, and Forum per i diritti dei bambini di Chernobyl in Italy from 2003 to 2006. Valeryia also worked as an interpreter at Belarusian State Television Company ONT in Minsk, Belarus in 2004.

Valeryia Ziablava's education history includes studying Economics at Belarus State Economic University from 2005 to 2006. Prior to that, they attended Minsk State Linguistic University from 1999 to 2004, where they completed a Bachelor's degree in Linguistics. Valeryia also holds a Master of Business Administration (M.B.A.) degree from SMC University, although the specific start and end years are not provided.

In addition to their formal education, Valeryia has obtained certifications in various fields. In June 2020, they completed the "CERTaIN: Pragmatic Clinical Trials and Healthcare Delivery Evaluations" certification from The University of Texas MD Anderson Cancer Center. The following year, in June 2019, they obtained the "Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines" certification from MIT xPRO.